Molecule Details
| InChIKey | MINDHVHHQZYEEK-HBBNESRFSA-N |
|---|---|
| Compound Name | Mupirocin |
| Canonical SMILES | C/C(=C\C(=O)OCCCCCCCCC(=O)O)C[C@@H]1OC[C@H](C[C@@H]2O[C@H]2[C@@H](C)[C@H](C)O)[C@@H](O)[C@H]1O |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.85 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB00410 |
|---|---|
| Drug Name | Mupirocin |
| CAS Number | 12650-69-0 |
| Groups | approved investigational vet_approved |
| ATC Codes | R01AX06 D06AX09 |
| Description | Mupirocin, formerly termed pseudomonic acid A,[A178531] is a novel antibacterial agent with a unique chemical structure and mode of action apart from other antibiotic agents. Produced by fermentation using the organism _Pseudomonas fluorescens_, mupirocin is a naturally-occurring antibiotic that dis... |
Categories: Anti-Bacterial Agents Anti-Infective Agents Antibiotics for Topical Use Dermatologicals Enzyme Inhibitors Epoxy Compounds Ethers Ethers, Cyclic Fatty Acids Lipids Nasal Preparations Protein Synthesis Inhibitors Pyrans RNA Synthetase Inhibitor Antibacterial RNA Synthetase Inhibitors
Cross-references: BindingDB: 50290686 ChEBI: 7025 CHEMBL719 ChemSpider: 393914 Drugs Product Database (DPD): 1832 C11758 D01076 PDB: MRC PharmGKB: PA164764568 PubChem:446596 PubChem:46505594 RxCUI: 42372 Therapeutic Targets Database: DAP000711 Wikipedia: Mupirocin ZINC: ZINC000004102194
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P41972 | ileS | Isoleucine--tRNA ligase | inhibitor | targets |